Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Phase I tolerability and safety reported for Agouron's AG-331

Nov. 15, 1996

AltaRex licenses alkylating agent for North America

Nov. 15, 1996

Scotia reports progress on Foscan

Nov. 8, 1996

Scotia's radioprotectant accepted for EMEA review

Nov. 8, 1996

New preclinical results reported for marimastat

Nov. 8, 1996

Preclinical results on angiogenesis inhibitor from NeXstar

Nov. 8, 1996

RGL protein for treatment of ras-related cancers

Nov. 8, 1996

Prizm and University of Pittsburgh receive STTR grant for antimelanoma MAb

Nov. 8, 1996

Novel tumor vaccine claimed by Boehringer Ingelheim

Nov. 8, 1996

Hormonal agents from Yamanouchi

Nov. 8, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...